Workflow
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
AVNSAvanos Medical(AVNS) Zacks Investment Research·2024-04-02 16:21

Avanos Medical, Inc. (AVNS) is well-poised for growth in the coming quarters, courtesy of its impressive product line. The optimism led by a solid fourth-quarter 2023 performance and continued focus on its research and development (R&D) are expected to contribute further. However, stiff competition and macroeconomic concerns persist.Over the past year, this Zacks Rank #3 (Hold) stock has lost 33.9% against the 9.8% rise of the industry and 27.6% growth of the S&P 500 Composite.The renowned medical device so ...